Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0700)

Milan 20133

1 studies enrolling now · 1 studies all time

What they study most

Gastrointestinal Cancer

Studies at this site

• Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02) — Recruiting now